Blog | Veristat Insightful Perspectives

Understanding When to Submit an IND Application to the FDA

An Interview with Kevin Hennegan, Senior Regulatory Strategist, Veristat

Read More

Selecting the Right EDC System for a Clinical Program

Understanding the Various Considerations for EDC Selection


Read More

Regulatory Guidance Monthly Review - October 2019

October 2019 Updates from FDA 

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance updates from the US Food & Drug Administration (FDA)  that are pertinent to the governance of clinical trials and drug, biologic, or medical device development and approval.   Below are the relevant links to updates provided in October 2019.


Read More